Dr. Ewa Elenberg, MD

NPI: 1255411591
Total Payments
$24,367
2022 Payments
$8,666
Companies
5
Transactions
39

Payment Breakdown by Category

Other$21,489 (88.2%)
Food & Beverage$1,490 (6.1%)
Travel$1,388 (5.7%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $18,987 6 77.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,502 1 10.3%
Food and Beverage $1,490 26 6.1%
Travel and Lodging $1,388 6 5.7%

Top Paying Companies

Company Total Records Latest Year
Horizon Therapeutics plc $13,318 18 $0 (2022)
Horizon Pharma plc $6,041 15 $0 (2018)
Leadiant Biosciences, Inc. $4,880 4 $0 (2019)
Retrophin, Inc. $103.32 1 $0 (2018)
RECORDATI_RARE_DISEASES_INC. $24.90 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2022 $8,666 13 Horizon Therapeutics plc ($8,666)
2021 $2,919 1 Horizon Therapeutics plc ($2,919)
2020 $1,460 1 Horizon Therapeutics plc ($1,460)
2019 $3,049 6 Leadiant Biosciences, Inc. ($2,751)
2018 $300.87 4 Horizon Pharma plc ($197.55)
2017 $7,972 14 Horizon Pharma plc ($5,844)

All Payment Transactions

39 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/14/2022 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $5,004.00 General
Category: PROCYSBI
11/14/2022 Horizon Therapeutics plc PROCYSBI (Drug) Travel and Lodging Cash or cash equivalent $395.20 General
Category: PROCYSBI
11/14/2022 Horizon Therapeutics plc PROCYSBI (Drug) Travel and Lodging Cash or cash equivalent $292.67 General
Category: PROCYSBI
11/14/2022 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $124.99 General
Category: PROCYSBI
11/14/2022 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $64.99 General
Category: PROCYSBI
11/14/2022 Horizon Therapeutics plc PROCYSBI (Drug) Travel and Lodging Cash or cash equivalent $52.35 General
Category: PROCYSBI
11/14/2022 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $49.99 General
Category: PROCYSBI
11/14/2022 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $24.99 General
Category: PROCYSBI
11/14/2022 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $24.36 General
Category: PROCYSBI
11/02/2022 Horizon Therapeutics plc PROCYSBI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,502.00 General
Category: PROCYSBI
09/11/2022 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage Cash or cash equivalent $32.00 General
Category: PROCYSBI
09/10/2022 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $64.07 General
Category: PROCYSBI
09/09/2022 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $34.08 General
Category: PROCYSBI
05/20/2021 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $2,919.00 General
Category: PROCYSBI
07/16/2020 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $1,460.00 General
Category: PROCYSBI
11/06/2019 RECORDATI_RARE_DISEASES_INC. Carbaglu (Drug) Food and Beverage Cash or cash equivalent $24.90 General
Category: Neurology
10/16/2019 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $143.90 General
Category: PROCYSBI
07/31/2019 Leadiant Biosciences, Inc. Cystaran (Drug) Honoraria Cash or cash equivalent $2,500.00 General
Category: Ophthalmic
07/31/2019 Leadiant Biosciences, Inc. Cystaran (Drug) Travel and Lodging Cash or cash equivalent $251.36 General
Category: Ophthalmic
04/29/2019 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $104.34 General
Category: PROCYSBI
04/29/2019 Horizon Therapeutics plc PROCYSBI (Drug) Food and Beverage In-kind items and services $24.67 General
Category: PROCYSBI
10/26/2018 Horizon Pharma plc PROCYSBI (Drug) Food and Beverage In-kind items and services $75.35 General
Category: PROCYSBI
09/26/2018 Horizon Pharma plc PROCYSBI (Drug) Food and Beverage In-kind items and services $97.72 General
Category: PROCYSBI
05/04/2018 Horizon Pharma plc PROCYSBI (Drug) Food and Beverage In-kind items and services $24.48 General
Category: PROCYSBI
04/25/2018 Retrophin, Inc. (815) Thiola (Drug) Food and Beverage In-kind items and services $103.32 General
Category: Kidney Stones

About Dr. Ewa Elenberg, MD

Dr. Ewa Elenberg, MD is a Pediatric Nephrology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255411591.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ewa Elenberg, MD has received a total of $24,367 in payments from pharmaceutical and medical device companies, with $8,666 received in 2022. These payments were reported across 39 transactions from 5 companies. The most common payment nature is "Honoraria" ($18,987).

Practice Information

  • Specialty Pediatric Nephrology
  • Location Houston, TX
  • Active Since 10/17/2006
  • Last Updated 04/27/2011
  • Taxonomy Code 2080P0210X
  • Entity Type Individual
  • NPI Number 1255411591

Products in Payments

  • PROCYSBI (Drug) $19,336
  • Cystaran (Drug) $4,880
  • (815) Thiola (Drug) $103.32
  • Carbaglu (Drug) $24.90
  • NO_PRODUCT (Drug) $22.95

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Nephrology Doctors in Houston